15-Year Study of More Than 5,000 Patients Reveals Key Factors in …
Business Wire (press release), CA - Dec 4, 2006The study of 5,889 patients over the course of 15 years is one of the largest conducted on prostate cancer treatment outcomes and found that formula and …
Source: home.businesswire.com

Quest PharmaTech Strengthens its Patent Protection for SonoLight …
CNW Telbec (Communiqu s de presse), Canada - Dec 5, 2006… A second product from the SonoLight platform, SL052, is an injectable formulation that is in late-stage pre-clinical development for prostate cancer treatment. …
Source: www.cnw.ca